PuSH - Publikationsserver des Helmholtz Zentrums München

Kasprzak, J.* ; Dulski, J.* ; Schinwelski, M.* ; Krygier, M.* ; Zech, M. ; Sławek, J.*

ACTB-associated dystonia-deafness syndrome with good response to DBS GPi revisited.

Clin. Parkinsonism Relat. Disord. 13:100406 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
INTRODUCTION: Dystonia-deafness syndrome is a rare disorder characterized by dystonia with sensorineural hearing impairment. While various genetic causes have been identified, many cases remain unexplained. Deep brain stimulation of the globus pallidus internus is an established treatment for dystonia, but outcomes vary depending on the underlying cause. METHODS: We conducted a long-term follow-up of a 31-year-old male diagnosed with DDS, initially reported in 2016. RESULTS: The patient exhibited progressive generalized dystonia and sensorineural hearing loss. At the age of 19, bilateral DBS-GPi implantation was performed, resulting in sustained symptom improvement until the age of 25. However, progressive worsening of dystonia led to the initiation of adjunctive botulinum toxin therapy, which initially provided symptom relief. At the age of 26, disruption of a DBS extension wire caused acute symptom exacerbation, necessitating surgical replacement. Further clinical deterioration was exacerbated by a hardware-related infection, leading to surgical removal of the left DBS system at the age of 30, which prompted placement of a percutaneous endoscopic gastrostomy. At the age of 31, the right-sided DBS system was also removed. Bilateral reimplantation of the DBS-GPi system was performed at the age of 31. Trio exome sequencing identified a de novo heterozygous pathogenic ACTB variant, p.Arg183Trp. CONCLUSION: This case highlights both the benefits and limitations of DBS in ACTB-associated dystonia. While this mutation may predict DBS efficacy, long-term outcomes are influenced by disease progression, hardware complications, and systemic factors. Further research is needed to establish ACTB variants as predictive markers for DBS responsiveness.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Actb ; Deep Brain Stimulation ; Dystonia ; Dystonia-deafness Syndrome ; Movement Disorders
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 2590-1125
e-ISSN 2590-1125
Quellenangaben Band: 13, Heft: , Seiten: , Artikelnummer: 100406 Supplement: ,
Verlag Elsevier
Begutachtungsstatus Peer reviewed
POF Topic(s) 30205 - Bioengineering and Digital Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-503200-001
PubMed ID 41334474
Erfassungsdatum 2025-12-04